The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. These symptoms include sneezing, stuffiness, discharge, and itching. Starting dose is 200 mcg for most patients, although dosing should be individualized based on such variables as degree of patient allergy and degree of pollen exposure. Allergic rhinitis, otherwise known as hay fever, occurs when the immune system reacts to pollens and other allergens.
Allergies can be hereditary or they can be triggered by environmental or even emotional conditions.
Clinical Results Eight controlled clinical trials investigated 746 patients with either perennial or seasonal allergic rhinitis. Results indicated that 200 mcg daily of the study drug significantly relieved nasal symptoms of the seasonal rhinitis. In rare cases, the development of localized infections of the nose and pharynx has occurred. It has been shown in clinical studies that intranasal corticosteroids may cause a reduction in growth velocity in pediatric patients. Pediatric patients should therefore be monitored closely when taking this medication.